(Reuters) -Pfizer Inc said on Monday it has filed a second lawsuit against Metsera and its controlling shareholders, as well ...
25mon MSN
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors ...
The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments that also tackle related conditions like diabetes and heart disease. Valued at ...
The start of a traditionally solid month on Wall Street saw stocks rising as Amazon.com Inc.’s $38 billion deal with OpenAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback